Wednesday, February 17, 2016 4:41:31 PM
NuGene partners with Celebrity Entrepeneur (WHO?) Kevin Harrington.
NuGene files provisional patent application to enhance wound treatment by
combining micro-current electro active dressing with human adipose-derived stem cell media. NAW, you don't say. Bet you never get the real patent
though. Any takers on the bet???
Management is making it very embarrassing for anyone to admit that they
are a shareholder in this joke.
Recent NUGN News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/16/2024 09:26:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 04:33:34 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/21/2023 07:14:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 01:26:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:26:56 PM
- Shares Rip As Firm Receives Form 10 Approval • AllPennyStocks.com • 11/02/2023 05:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 10:11:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 10:09:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 10:07:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 10:05:23 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/25/2023 06:47:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 03:23:55 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/28/2023 05:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 03:27:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM